Cell therapy developer Adaptimmune, with operations at the Philadelphia Navy Yard and in the UK, plans to reduce its workforce by 33% next year to cut costs. Most layoffs will occur in Q1, impacting about 170 of its 500 employees. The company did not specify how many jobs would be affected at its South Philadelphia… Read more »